Evidence map›Paper›PMID 42030338›Full record

ArticlePLoS neglected tropical diseases2026

A functional crosstalk between circulating follicular helper 2 T cells and memory B cells drives anti-Plasmodium vivax antibodies.

Zulfa Zahra Salsabila, Piyawan Kochayoo, Tipanan Khunsri, Pachara Tianpothong, Chaniya Leepiyasakulchai, Pongsakorn Thawornpan, Julius Clemence R Hafalla, John H Adams, Patchanee Chootong

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zulfa Zahra SalsabilaDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Piyawan KochayooDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Tipanan KhunsriDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Pachara TianpothongDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Chaniya LeepiyasakulchaiDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Pongsakorn ThawornpanDepartment of Community Medical Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Julius Clemence R HafallaDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
John H AdamsCenter for Global Health and Inter-Disciplinary Research, College of Public Health, University of South Florida, Tampa, Florida, United States of America.
Patchanee ChootongDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0001-6892-4494

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe induction of long-term humoral immune responses depends upon the interaction between T follicular helper (Tfh) and B cells in germinal centers, leading to development of memory B cells (MBCs) and class-switched antibodies. Expansion and activation of circulating Tfh2 (cTfh2) cells were detected in both vivax and falciparum malaria subjects. However, how these cells help B cells generate anti-malarial immunity is still unclear. Here, we assessed the breadth and competency of antibody responses from P. vivax subjects and related them to the frequency and activation status of cTfh2 subset. We also demonstrated the ability of P. vivax antigen to trigger cTfh2 cell activation and the function of cTfh2 cells to help MBCs secrete antibodies. METHODOLOGY/PRINCIPAL

findingsOf 40 subjects with acute P. vivax malaria, 23 were seropositive for anti-PvDBPII antibodies (High and Low responders). Three High Responders (HRs) produced inhibitory antibodies against PvDBPII-human erythrocyte binding. An expansion of cTfh2 cells was detected in seropositive subjects. While their frequency did not differ significantly between High and Low Responders (LRs), the expression of co-stimulatory molecule ICOS in cTfh2 cells was higher in HRs. Activation of cTfh2 cells was specifically stimulated by PvDBPII antigen. In cTfh2-MBC co-cultures, proliferation and activation of cTfh2 cells were detected after receiving signal from MBCs. These activated cTfh2 cells then promoted MBC differentiation into antibody secreting cells (ASCs) which secreted anti-PvDBPII IgG. A decrease in cTfh2 cell activation was observed upon the addition of IFN-γ to the co-cultures. Importantly, cTfh2 cells played a role in producing anti-malarial specific antibodies. CONCLUSIONS/SIGNIFICANCE: This study demonstrated that activation of cTfh2 cells, marked by the upregulation of ICOS molecules, was notably observed in subjects who produced high titers of anti-PvDBPII antibodies in response to P. vivax infection. This was also seen in a few subjects who produced high levels of antibody with inhibitory function. The PvDBPII antigen specifically stimulated cTfh2 cell proliferation and activation. Additionally, interactions between cTfh2 cells and MBCs promoted both cTfh2 activation and anti-PvDBPII antibody secretion.

Indexed as

Antibodies, ProtozoanMalaria, VivaxMemory B CellsPlasmodium vivaxT Follicular Helper CellsTh2 CellsAdultAntigens, ProtozoanFemaleHumansInducible T-Cell Co-Stimulator ProteinLymphocyte ActivationMaleYoung AdultAntibodies, ProtozoanAntigens, ProtozoanInducible T-Cell Co-Stimulator Protein

Identifiers

PMID42030338
PMCPMC13108860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.